Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - Case report

[1] Dusheiko G(1997)Side effects of alpha interferon in chronic hepatitis C Hepatology 26 112S-121S

[2] Negro F(2010)Adverse effects of drugs in the treatment of viral hepatitis Best Pract Res Clin Gastroenterol 24 183-92

[3] Naranjo CA(1981)A method for estimating the probability of adverse drug reactions Clin Pharmacol Ther 30 239-45

[4] Busto U(2005)IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors Annu Rev Immunol 23 275-306

[5] Sellers EM(2007)Cardiotoxic properties of interferon: aggravation of atrio-ventricular block during treatment of chronic hepatitis C with peginterferon--a case report Pol Arch Med Wewn 117 49-52

[6] Liu YJ(1992)Effects of interleukin-1 beta on blood pressure, sympathetic nerve activity, and pituitary endocrine functions in anesthetized rats Am J Hypertens 5 224-9

[7] Rechciński T(2004)Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology Eur Heart J 25 587-610

[8] Matusik D(2007)Severe pleuropericarditis and cardiomyopathy induced by high dose interferon alpha-2b Isr Med Assoc J 9 486-7

[9] Rudziński T(1996)Pericarditis during interferon-alpha therapy in chronic myelogenous leukemia Haematologica 81 484-6

[10] Takahashi H(2007)Treatment of hepatitis C in hemodialysis patients with pegylated interferon alpha-2a as monotherapy Ren Fail 29 961-6

[1] Dusheiko G(1997)Side effects of alpha interferon in chronic hepatitis C Hepatology 26 112S-121S

[2] Negro F(2010)Adverse effects of drugs in the treatment of viral hepatitis Best Pract Res Clin Gastroenterol 24 183-92

[3] Naranjo CA(1981)A method for estimating the probability of adverse drug reactions Clin Pharmacol Ther 30 239-45

[4] Busto U(2005)IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors Annu Rev Immunol 23 275-306

[5] Sellers EM(2007)Cardiotoxic properties of interferon: aggravation of atrio-ventricular block during treatment of chronic hepatitis C with peginterferon--a case report Pol Arch Med Wewn 117 49-52

[6] Liu YJ(1992)Effects of interleukin-1 beta on blood pressure, sympathetic nerve activity, and pituitary endocrine functions in anesthetized rats Am J Hypertens 5 224-9

[7] Rechciński T(2004)Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology Eur Heart J 25 587-610

[8] Matusik D(2007)Severe pleuropericarditis and cardiomyopathy induced by high dose interferon alpha-2b Isr Med Assoc J 9 486-7

[9] Rudziński T(1996)Pericarditis during interferon-alpha therapy in chronic myelogenous leukemia Haematologica 81 484-6

[10] Takahashi H(2007)Treatment of hepatitis C in hemodialysis patients with pegylated interferon alpha-2a as monotherapy Ren Fail 29 961-6